REASSURE AV Registry

NCT01074034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 211

Last updated 2017-08-01

Study results available
· View outcomes & findings →

Summary

Long term follow-up to monitor safety for patients implanted with a B301 ASSURE device.

Conditions

Interventions

DEVICE

AV Therapy Assessment-B301 investigational device

Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074034 on ClinicalTrials.gov